Polymorphisms in genes of relevance for oestrogen and oxytocin pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma: A pooled analysis from the BEACON consortium

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Lagergren, Katarina ^a   Ek, Weronica E ^b,c   Levine, David ^d   Chow, Wong Ho ^e   Bernstein, Leslie ^f   Casson, Alan G ^g   Risch, Harvey A ^h   Shaheen, Nicholas J ⁱ   Bird, NigelC ^j   Reid, Brian J ^k   Corley, Douglas A ^l   Hardie, Laura J ^m   Wu, Anna H ⁿ   Fitzgerald, Rebecca C ^o   Pharoah, Paul ^p   Caldas, Carlos ^p   Romero, Yvonne ^q   Vaughan, Thomas L ^k   Macgregor, Stuart ^b   Whiteman, David ^b   Westberg, Lars ^r   Nyren, Olof ^a   Lagergren, Jesper ^a,s   more..

^a KAROLINSKA INSTITUTE   (Sweden)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c SCIENCE FOR LIFE LABORATORY   (Sweden)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^g UNIVERSITY OF SASKATCHEWAN   (Canada)

^h YALE UNIVERSITY   (United States)

ⁱ UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF SHEFFIELD   (United Kingdom)

^k USA   (United States)

^l DIVISION OF RESEARCH   (United States)

^m UNIVERSITY OF LEEDS   (United Kingdom)

ⁿ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^o UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^p UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^q MAYO CLINIC   (United States)

^r UNIVERSITY OF GOTHENBURG   (Sweden)

^s KING'S COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; CYCLIC ADENOSINE DIPHOSPHATE RIBOSE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; OXYTOCIN; OXYTOCIN RECEPTOR; PEPTIDE HORMONE; PROTEIN CD38; PROTEIN ESR1; PROTEIN ESR2; PROTEIN OXT; UNCLASSIFIED DRUG; CD38 ANTIGEN; CD38 PROTEIN, HUMAN; CYP19A1 PROTEIN, HUMAN; ESR2 PROTEIN, HUMAN; ESTROGEN RECEPTOR ALPHA, HUMAN; MEMBRANE PROTEIN; OXTR PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; AUSTRALIA; BARRETT ESOPHAGUS; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; EUROPE; FEMALE; FOLLOW UP; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NORTH AMERICA; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; ADENOCARCINOMA; ESOPHAGEAL NEOPLASMS; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; PROCEDURES;

ADENOCARCINOMA; ANTIGENS, CD38; AROMATASE; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; OXYTOCIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, OXYTOCIN; SEX FACTORS;

EID: 84947795687     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138738     Document Type: Article

References (43)

1. Edgren G, Adami HO, Weiderpass Vainio E, Nyren O. A global assessment of the oesophageal adenocarcinoma epidemic. Gut. 2013;62(10):1406-14. Epub 2012/08/25. doi: 10.1136/gutjnl-2012-302412 PMID: 22917659.
2. Alexandropoulou K, van Vlymen J, Reid F, Poullis A, Kang JY. Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study. European journal of gastroenterology & hepatology. 2013;25(1):15-21. Epub 2012/10/02. doi: 10.1097/MEG. 0b013e3283595086 PMID: 23022985.
3. Lagergren J, Lagergren P. Recent developments in esophageal adenocarcinoma. CA: a cancer journal for clinicians. 2013;63(4):232-48. Epub 2013/07/03. doi: 10.3322/caac.21185 PMID: 23818335.
4. Derakhshan MH, Liptrot S, Paul J, Brown IL, Morrison D, McColl KE. Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17 year delayed development in females. Gut. 2009;58(1):16-23. PMID: 18838486. doi: 10.1136/gut.2008.161331
5. Rutegard M, Shore R, Lu Y, Lagergren P, Lindblad M. Sex differences in the incidence of gastrointestinal adenocarcinoma in Sweden 1970-2006. Eur J Cancer. 2010;46(6):1093-100. Epub 2010/03/02. doi: 10.1016/j.ejca.2010.01.029 PMID: 20188539.
6. Akgun H, Lechago J, Younes M. Estrogen receptor-beta is expressed in Barrett's metaplasia and associated adenocarcinoma of the esophagus. Anticancer research. 2002;22(3):1459-61. PMID: 12168823.
7. Chandanos E, Lagergren J. The mystery of male dominance in oesophageal cancer and the potential protective role of oestrogen. Eur J Cancer. 2009;45(18):3149-55. PMID: 19804965. doi: 10.1016/j. ejca.2009.09.001
8. Sukocheva OA, Wee C, Ansar A, Hussey DJ, Watson DI. Effect of estrogen on growth and apoptosis in esophageal adenocarcinoma cells. Dis Esophagus. 2012. Epub 2012/11/21. doi: 10.1111/dote.12000 PMID: 23163347.
9. Grover S, Talwar P, Baghel R, Kaur H, Gupta M, Gourie-Devi M, et al. Genetic variability in estrogen disposition: Potential clinical implications for neuropsychiatric disorders. American journal of medical genetics Part B, Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics. 2010;153B(8):1391-410. Epub 2010/10/05. doi: 10.1002/ajmg.b.31119 PMID: 20886541.
10. Schuit SC, de Jong FH, Stolk L, Koek WN, van Meurs JB, Schoofs MW, et al. Estrogen receptor alpha gene polymorphisms are associated with estradiol levels in postmenopausal women. European journal of endocrinology/European Federation of Endocrine Societies. 2005;153(2):327-34. Epub 2005/08/03. doi: 10.1530/eje.1.01973 PMID: 16061840.
11. Cronin-Fenton DP, Murray LJ, Whiteman DC, Cardwell C, Webb PM, Jordan SJ, et al. Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis. Eur J Cancer. 2010;46(11):2067-76. PMID: 20456945. doi: 10.1016/j.ejca.2010.03.032
12. Bodelon C, Anderson GL, Rossing MA, Chlebowski RT, Ochs-Balcom HM, Vaughan TL. Hormonal factors and risks of esophageal squamous cell carcinoma and adenocarcinoma in postmenopausal women. Cancer prevention research. 2011;4(6):840-50. Epub 2011/04/21. doi: 10.1158/1940-6207. CAPR-10-0389 PMID: 21505180; PubMed Central PMCID: PMC3107894.
13. Viero C, Shibuya I, Kitamura N, Verkhratsky A, Fujihara H, Katoh A, et al. REVIEW: Oxytocin: Crossing the bridge between basic science and pharmacotherapy. CNS neuroscience & therapeutics. 2010;16(5):e138-56. Epub 2010/07/16. doi: 10.1111/j.1755-5949.2010.00185.x PMID: 20626426; PubMed Central PMCID: PMC2972642.
14. Monstein HJ, Grahn N, Truedsson M, Ohlsson B. Oxytocin and oxytocin-receptor mRNA expression in the human gastrointestinal tract: a polymerase chain reaction study. Regulatory peptides. 2004;119(1-2):39-44. Epub 2004/04/20. doi: 10.1016/j.regpep. 2003.12.017 PMID: 15093695.
15. Jansson C, Johansson AL, Nyren O, Lagergren J. Socioeconomic factors and risk of esophageal adenocarcinoma: a nationwide Swedish case-control study. Cancer Epidemiol Biomarkers Prev. 2005;14(7):1754-61. PMID: 16030113.
16. Gouin JP, Carter CS, Pournajafi-Nazarloo H, Glaser R, Malarkey WB, Loving TJ, et al. Marital behavior, oxytocin, vasopressin, and wound healing. Psychoneuroendocrinology. 2010;35(7):1082-90. Epub 2010/02/11. doi: 10.1016/j.psyneuen. 2010.01.009 PMID: 20144509; PubMed Central PMCID: PMC2888874.
17. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. The New England journal of medicine. 1999;340(11):825-31. PMID: 10080844.
18. Rubenstein JH, Taylor JB. Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux. Alimentary pharmacology & therapeutics. 2010;32(10):1222-7. Epub 2010/10/20. doi: 10.1111/j.1365-2036.2010.04471.x PMID: 20955441; PubMed Central PMCID: PMC3481544.
19. Taylor JB, Rubenstein JH. Meta-analyses of the effect of symptoms of gastroesophageal reflux on the risk of Barrett's esophagus. The American journal of gastroenterology. 2010;105(8):1729, 30-7; quiz 38. Epub 2010/05/21. doi: 10.1038/ajg.2010.194 PMID: 20485283; PubMed Central PMCID: PMC2916949.
20. Jin D, Liu HX, Hirai H, Torashima T, Nagai T, Lopatina O, et al. CD38 is critical for social behaviour by regulating oxytocin secretion. Nature. 2007;446(7131):41-5. Epub 2007/02/09. doi: 10.1038/nature05526 PMID: 17287729.
21. Walum H, Lichtenstein P, Neiderhiser JM, Reiss D, Ganiban JM, Spotts EL, et al. Variation in the oxytocin receptor gene is associated with pair-bonding and social behavior. Biological psychiatry. 2012;71(5):419-26. Epub 2011/10/22. doi: 10.1016/j.biopsych.2011.09.002 PMID: 22015110; PubMed Central PMCID: PMC3266986.
22. Johansson A, Bergman H, Corander J, Waldman ID, Karrani N, Salo B, et al. Alcohol and aggressive behavior in men-moderating effects of oxytocin receptor gene (OXTR) polymorphisms. Genes, brain, and behavior. 2012;11(2):214-21. Epub 2011/10/20. doi: 10.1111/j.1601-183X.2011.00744.x PMID: 22008269.
23. Levine DM, Ek WE, Zhang R, Liu X, Onstad L, Sather C, et al. A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nature genetics. 2013;45(12):1487-93. Epub 2013/10/15. doi: 10.1038/ng.2796 PMID: 24121790; PubMed Central PMCID: PMC3840115.
24. Ek WE, Levine DM, D'Amato M, Pedersen NL, Magnusson PK, Bresso F, et al. Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux. Journal of the National Cancer Institute. 2013;105(22):1711-8. Epub 2013/10/31. doi: 10.1093/jnci/djt303 PMID: 24168968; PubMed Central PMCID: PMC3833931.
25. Liu JZ, McRae AF, Nyholt DR, Medland SE, Wray NR, Brown KM, et al. A versatile gene-based test for genome-wide association studies. American journal of human genetics. 2010;87(1):139-45. Epub 2010/07/06. doi: 10.1016/j.ajhg.2010.06.009 PMID: 20598278; PubMed Central PMCID: PMC2896770.
26. Konda VJ, Waxman I. Endotherapy for Barrett's esophagus. The American journal of gastroenterology. 2012;107(6):827-33. Epub 2012/04/11. doi: 10.1038/ajg.2012.70 PMID: 22488078.
27. Nilsson S, Gustafsson JA. Estrogen receptors: therapies targeted to receptor subtypes. Clinical pharmacology and therapeutics. 2011;89(1):44-55. Epub 2010/12/03. doi: 10.1038/clpt.2010.226 PMID: 21124311.
28. Thomas C, Gustafsson JA. The different roles of ER subtypes in cancer biology and therapy. Nature reviews. 2011;11(8):597-608. Epub 2011/07/23. doi: 10.1038/nrc3093 PMID: 21779010.
29. Morita T, Shibata K, Kikkawa F, Kajiyama H, Ino K, Mizutani S. Oxytocin inhibits the progression of human ovarian carcinoma cells in vitro and in vivo. International journal of cancer Journal international du cancer. 2004;109(4):525-32. Epub 2004/03/03. doi: 10.1002/ijc.20017 PMID: 14991573.
30. Cassoni P, Fulcheri E, Carcangiu ML, Stella A, Deaglio S, Bussolati G. Oxytocin receptors in human adenocarcinomas of the endometrium: presence and biological significance. The Journal of pathology. 2000;190(4):470-7. Epub 2000/03/04. doi: 10.1002/(sici) 1096-9896 (200003) 190:4<470::aidpath550> 3.0.co;2-g PMID: 10699997.
31. Whittington K, Connors B, King K, Assinder S, Hogarth K, Nicholson H. The effect of oxytocin on cell proliferation in the human prostate is modulated by gonadal steroids: implications for benign prostatic hyperplasia and carcinoma of the prostate. The Prostate. 2007;67(10):1132-42. Epub 2007/05/12. doi: 10.1002/pros.20612 PMID: 17492653.
32. Novak JF, Judkins MB, Chernin MI, Cassoni P, Bussolati G, Nitche JA, et al. A plasmin-derived hexapeptide from the carboxyl end of osteocalcin counteracts oxytocin-mediated growth inhibition [corrected] of osteosarcoma cells. Cancer research. 2000;60(13):3470-6. Epub 2000/07/26. PMID: 10910058.
33. Cassoni P, Sapino A, Negro F, Bussolati G. Oxytocin inhibits proliferation of human breast cancer cell lines. Virchows Archiv: an international journal of pathology. 1994;425(5):467-72. Epub 1994/01/01. PMID: 7850070.
34. Cassoni P, Sapino A, Stella A, Fortunati N, Bussolati G. Presence and significance of oxytocin receptors in human neuroblastomas and glial tumors. International journal of cancer Journal international du cancer. 1998;77(5):695-700. Epub 1998/08/04. PMID: 9688301.
35. Velasco J, Hernandez JL, Perez-Castrillon JL, Zarrabeitia MT, Alonso MA, Gonzalez-Macias J, et al. Haplotypes of intron 4 of the estrogen receptor alpha gene and hip fractures: a replication study in Caucasians. BMC medical genetics. 2010;11:16. Epub 2010/01/30. doi: 10.1186/1471-2350-11-16 PMID: 20109228; PubMed Central PMCID: PMC2837017.
36. Dunning AM, Healey CS, Baynes C, Maia AT, Scollen S, Vega A, et al. Association of ESR1 gene tagging SNPs with breast cancer risk. Human molecular genetics. 2009;18(6):1131-9. Epub 2009/01/08. doi: 10.1093/hmg/ddn429 PMID: 19126777; PubMed Central PMCID: PMC2722230.
37. Dahlgren A, Lundmark P, Axelsson T, Lind L, Syvanen AC. Association of the estrogen receptor 1 (ESR1) gene with body height in adult males from two Swedish population cohorts. PloS one. 2008;3(3):e1807. Epub 2008/03/20. doi: 10.1371/journal.pone.0001807 PMID: 18350145; PubMed Central PMCID: PMC2265544.
38. Keene KL, Mychaleckyj JC, Smith SG, Leak TS, Perlegas PS, Langefeld CD, et al. Comprehensive evaluation of the estrogen receptor alpha gene reveals further evidence for association with type 2 diabetes enriched for nephropathy in an African American population. Human genetics. 2008;123(4):333-41. Epub 2008/02/29. doi: 10.1007/s00439-008-0482-z PMID: 18305958; PubMed Central PMCID: PMC2752813.
39. Tobias JH, Steer CD, Vilarino-Guell C, Brown MA. Effect of an estrogen receptor-alpha intron 4 polymorphism on fat mass in 11-year-old children. The Journal of clinical endocrinology and metabolism. 2007;92(6):2286-91. Epub 2007/04/05. doi: 10.1210/jc.2006-2447 PMID: 17405848.
40. Levran O, Randesi M, Li Y, Rotrosen J, Ott J, Adelson M, et al. Drug addiction and stress-response genetic variability: association study in African Americans. Annals of human genetics. 2014;78(4):290-8. Epub 2014/04/29. doi: 10.1111/ahg.12064 PMID: 24766650; PubMed Central PMCID: PMC4065216.
41. Stankova T, Eichhammer P, Langguth B, Sand PG. Sexually dimorphic effects of oxytocin receptor gene (OXTR) variants on Harm Avoidance. Biology of sex differences. 2012;3(1):17. Epub 2012/08/01. doi: 10.1186/2042-6410-3-17 PMID: 22846218; PubMed Central PMCID: PMC3472235.
42. Kim J, Stirling KJ, Cooper ME, Ascoli M, Momany AM, McDonald EL, et al. Sequence variants in oxytocin pathway genes and preterm birth: a candidate gene association study. BMC medical genetics. 2013;14:77. Epub 2013/07/31. doi: 10.1186/1471-2350-14-77 PMID: 23889750; PubMed Central PMCID: PMC3737028.
43. Wellcome Trust Case Control C. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature. 2007;447(7145):661-78. Epub 2007/06/08. doi: 10.1038/nature05911 PMID: 17554300; PubMed Central PMCID: PMC2719288.